RAMJA GENOSENSOR has developed a fast, simple, and cost-effective solution for all hospitals, laboratories, and remote areas: a noble paper-based system that detects microbial infection and antimicrobial resistance within 2 hours. Our device is ultrasensitive, gene specific, portable, precise, compact, and user-friendly in almost every way. Unlike existing experiments (2-3 days result waiting) however, the PRATHAMASENSE gives results in less than 2 hours, saving both lives and money for hospitals. It is cost-efficient than conventional research approaches such as culture and PCR as it can reduce cost, efforts & resources by huge margin. read more
Nanoshot starts killing germs within 30 seconds and completely kill them in 10 minutes, Overall, Nanoshot has shown an efficacy rate of 99.9% on the bacteria, viruses, and fungi, and the effect lasts for four days (96 hours) after a single application. As a result, there is no need to reapply the Nanoshot every few hours; only one application will be sufficient for the next four days and the amount of Nanoshot used per unit area is lower. Germ-free surfaces and proper sanitation remains our priority. We Validated Nanoshot results in NABL accredited LAB & it is our patented formulation. read more
🛑 Problem: Conventional diagnostics are slow, expensive, and infrastructure-heavy—especially unsuitable for low-resource or emergency settings. ✅ Solution: Prathamasense is a patented, portable DNA biosensor platform that delivers full infection and AMR profiling in just 90 minutes from any biological fluid. 🧬 Genomic Profile Enables: • Multi-pathogen detection in blood, urine, CSF, bile, BAL, etc. • Simultaneous detection of bacteria, fungi, and resistance genes • Reduces diagnosis time from days to minutes, even in basic labs
🛑 Problem: Most disinfectants evaporate quickly, require frequent application, and can damage skin or surfaces. ✅ Solution: Nanoshot is an organic, alcohol-free surface disinfectant that kills 99.9% of bacteria, viruses, and fungi (including MRSA) within 30 seconds and protects surfaces for up to 96 hours. 🧬 Genomic Profile Enables: • Effective disinfection of resistant strains like MRSA • Proven through NABL-accredited lab testing and dermatological validation • Offers preventive hygiene solution in healthcare and public settings
🛑 Problem: AMR claims a life every 45 seconds. Conventional culture methods take 3–4 days, causing delays and excessive use of broad-spectrum antibiotics. ✅ Solution: Our genosensor identifies key resistance genes in under 90 minutes, helping clinicians prescribe the right antibiotic immediately—curbing misuse and combating superbugs. 🧬 Genomic Profile Enables: • Detection of resistance genes: KPC, NDM, OXA-48, OXA-23, IMP, VIM (Carbapenemases) • MCR-1 (Colistin), CTX-M (ESBL), MecA (MRSA), VanA (VRE) • Enables specific antibiotic targeting instead of empirical therapy
🛑 Problem: Sepsis in ICU patients requires urgent intervention. Diagnostic delays increase mortality by up to 80%. ✅ Solution: Our Sepsis Panel detects both the causative organism and AMR genes from blood or body fluid in 90 minutes—enabling immediate and targeted treatment. 🧬 Genomic Profile Enables: • Pathogen ID: E. coli, K. pneumoniae, A. baumannii, P. aeruginosa, S. aureus, E. faecalis, C. albicans • Resistance detection: KPC, NDM, OXA-48, CTX-M (ESBL), MCR-1 (Colistin), MecA (MRSA) • Guides fast antibiotic decisions based on real-time resistance profile
🛑 Problem: UTIs are often mismanaged due to slow diagnostics, leading to recurrence and resistance buildup. ✅ Solution: Our UTI Panel detects bacterial strains and AMR markers in urine within 90 minutes, allowing personalized and timely antibiotic therapy. 🧬 Genomic Profile Enables: • Bacteria detected: E. coli, K. pneumoniae, P. aeruginosa, A. baumannii, P. mirabilis • Gram-positive: S. aureus, E. faecalis, S. saprophyticus • AMR markers: CTX-M (ESBL), MecA (MRSA), MCR-1 (Colistin) • Helps avoid blanket antibiotic use and improves clinical precision
🛑 Problem: Fungal infections are life-threatening in immunocompromised patients, and current detection methods are often too slow. ✅ Solution: Our fungal panels identify multiple Candida and mould species within 90 minutes from any body fluid—crucial for early intervention. 🧬 Genomic Profile Enables: • Detection of: Candida albicans, C. auris, C. glabrata, C. krusei, C. tropicalis, Aspergillus fumigatus, Rhizopus, Mucor • Enables targeted antifungal therapy and supports early management in ICU and oncology settings